References
- Potolog-Nahari C, Fishman A, Cohen I. Protection of ovarian function and fertility using a combination of gonadotropin-releasing hormone (GnRH) agonist and GnRH antagonist during cancer treatment in young females. Gynecol Endocrinol 2007; 23: 290–294
- Licciardi F L, Liu H C, Rosenwaks Z. Day 3 estradiol serum concentrations as prognosticators of ovarian stimulation response and pregnancy outcome in patients undergoing in vitro fertilization. Fertil Steril 1995; 64: 991–994
- Scott R T, Toner J P, Muasher S J, Oehninger S, Robinson S, Rosenwaks Z. Follicle-stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome. Fertil Steril 1989; 51: 651–654
- Sklar C A, Mertens A C, Mitby P, Whitton J, Stovall M, Kasper C, Mulder J, Green D, Nicholson H S, Yasui Y, et al. Premature menopause in survivors of childhood cancer: a report from the childhood cancer survivor study. J Natl Cancer Inst 2006; 98: 890–896
- Waxman J H, Ahmed R, Smith D, Wrigley P F, Gregory W, Shalet S, Crowther D, Rees L H, Besser G M, Malpas J S. Failure to preserve fertility in patients with Hodgkin's disease. Cancer Chemother Pharmacol 1987; 19: 159–162
- Sonmezer M, Oktay K. Fertility preservation in female patients. Hum Reprod Update 2004; 10: 251–266
- Meirow D, Lewis H, Nugent D, Epstein M. Subclinical depletion of primordial follicular reserve in mice treated with cyclophosphamide: clinical importance and proposed accurate investigative tool. Hum Reprod 1999; 14: 1903–1907
- Cheng C K, Leung P C. Molecular biology of gonadotropin-releasing hormone (GnRH)-I, GnRH-II, and their receptors in humans. Endocr Rev 2005; 26: 283–306
- Danforth D R, Arbogast L K, Friedman C I. Acute depletion of murine primordial follicle reserve by gonadotropin-releasing hormone antagonists. Fertil Steril 2005; 83: 1333–1338
- Vitale A M, Abramovich D, Peluffo M C, Meresman G, Tesone M. Effect of gonadotropin-releasing hormone agonist and antagonist on proliferation and apoptosis of human luteinized granulosa cells. Fertil Steril 2006; 85: 1064–1067
- Oktay K, Sönmezer M, Öktem O, Fox K, Emons G, Bang H. Absence of the conclusive evidence for the safety and efficacy of the gonadotropin releasing hormone analog treatment in protecting against chemotherapy-induced gonadal injury. Oncologist 2007; 12: 1055–1066